BiotechTube
Home/AS2 Bio/Allyson Berent
AB

Allyson Berent

Chief Development Officer

AS2 Bio

Therapeutic Areas

Angelman syndromeNeurodevelopmental Disorders

AS2 Bio Pipeline

DrugIndicationPhase
Undisclosed Pipeline ProgramsAngelman syndromePre-clinical

Leadership Team at AS2 Bio

JP
Jennifer Panagoulias
Chief Operating Officer
View full AS2 Bio profile